Tag: obesity
Browse all articles tagged with “obesity”.
3 articles
Retatrutide: The Triple Agonist Setting New Records in Obesity Research
A research-focused overview of retatrutide (LY3437943), the investigational triple GIP/GLP-1/glucagon receptor agonist from Eli Lilly that achieved 23.7% body weight reduction in Phase 2 trials, the largest ever recorded in an obesity trial.
Mazdutide: The Dual GLP-1/Glucagon Agonist From Innovent Biologics
A research overview of mazdutide (IBI362), the dual GLP-1/glucagon receptor agonist developed by Innovent Biologics for the Chinese and global markets, with Phase 3 data showing significant weight loss and metabolic improvements.
Adipotide (FTPP): The Fat Vasculature-Targeting Peptide With Primate Data and Safety Concerns
A detailed research overview of adipotide (FTPP/prohibitin-targeting peptide), the chimeric peptide that targets white fat tissue vasculature for apoptosis, examining its dramatic primate weight loss data alongside significant safety and toxicity concerns.
For informational purposes only. Not medical advice. Always consult with qualified healthcare professionals.